There is no current national screening programme for prostate cancer; the committee that decides these things is looking into ...

This year, more than 13,000 Pennsylvanians will be diagnosed with prostate cancer and nearly 1,500 will die from it. Proposed ...

Medically reviewed by Archana Sharma, DO The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three ...

Medicare covers one annual prostate-specific antigen (PSA) test for people with prostates if they meet the eligibility guidelines and the test is medically necessary. Medicare typically covers one ...

Prostate cancer is the malignant growth of cells in the prostate, a walnut-sized gland below the bladder, that is responsible ...

Dr. Paul Gellhaus says PSA testing and modern biopsy methods ease fears and reassure patients, making early prostate cancer ...

Prostate cancer screening is essential for early detection, especially in high-risk groups like men over 50, African Americans, and those with a family history. Routine screening, including PSA tests ...

Although Black men die of prostate cancer at twice the rate of the rest of U.S. males, this fact often is not known or ...

The most common screening test for prostate cancer so often returns a false positive result that it's no longer recommended for men older than 70, and it's offered as a personal choice for younger men ...

A new British study suggests that the prostate-specific antigen (PSA) test, long used to spot prostate cancers, might lead to overdiagnosis in Black men. Researchers now theorize that Black men may ...

In tandem with September’s Prostate Cancer Awareness Month, Cleveland Diagnostics is kicking off a campaign to boost awareness of and education around screening tests for the disease. The flagship ...